Table 2.
Comparison of total intracranial volume.
| NQ | FS | HAD | p | NQ vs. FS | NQ vs. HAD | FS vs. HAD | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| p | ICC | d | p | ICC | d | p | ICC | d | |||||
| Total | 1427.37 ± 152.94 | 1414.41 ± 142.18 | 1381.46 ± 140.69 | <0.001 | 0.101 | 0.967 (0.948–0.979) | 0.088 | <0.001 | 0.926 (0.885–0.953) | 0.312 | <0.001 | 0.961 (0.939–0.975) | 0.233 |
| Non-AD | 1473.69 ± 158.79 | 1446.49 ± 144.85 | 1420.02 ± 139.01 | <0.001 | 0.007 | 0.965 (0.936–0.981) | 0.179 | 0.04 | 0.894 (0.808–0.942) | 0.360 | 0.040 | 0.937 (0.886–0.966) | 0.186 |
| AD | 1364.21 ± 120.35 | 1370.66 ± 127.97 | 1328.89 ± 126.94 | <0.001 | 1.000 | 0.971 (0.941–0.986) | 0.052 | <0.001 | 0.960 (0.919–0.980) | 0.286 | <0.001 | 0.992 (0.983–0.996) | 0.286 |
Note—Data are presented as mean ± standard deviation and intraclass correlation coefficient with 95% confidence interval and effect size (d). AD, Alzheimer’s disease; FS, FreeSurfer; HAD, Heuron AD; NQ, NeuroQuant.